Investment Insights
We partner with Hedge Funds, Private Equity houses, Venture Capital firms, Private / Angel investors, startups and entrepreneurs, providing timely and actionable research and insights that yield a competitive advantage.
From uncovering hidden investment opportunities and identifying emerging investment trends, to supporting a due-diligence process with crucial intelligence, we can provide timely and insightful recommendations for our clients.
Our insights and advisory focus on:
- Landscape analysis, including scientific and commercial due diligence
- Company / asset profiling, including addressable market size, growth drivers and expected growth, segmentation, value proposition etc.
- Decision-making opportunity / risk assessment, both for investors and their portfolio companies
- Other research and advisory, customized to our clients’ needs
We also provide fundraising services, by connecting entrepreneurs and companies who seek the all-important capital to kick-start or grow their venture with potential investors from our extensive network of contacts.
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, related to trending news from the investment space.
Want to make informed investments and capitalize on key opportunities? Let’s connect!
Reach out to info@lqventures.com to learn more about our strategic consulting and research capabilities.
December 1, 2025
Hematology Today—December 1, 2025
December 1, 2025
Oncology Today—December 1, 2025
December 1, 2025
AI in Healthcare and Digital Health Today—December 1, 2025
November 30, 2025
Lucid Diligence Brief: Zetagen $12.9 million Series B1 in breast cancer
November 29, 2025
Lucid Diligence Brief: Imugene onCARlytics Carteyva collaboration
November 28, 2025
Respiratory Video Recap—November 28, 2025
November 28, 2025
Vaccines Video Recap—November 28, 2025
November 28, 2025
Public Health Today—28 November, 2025
November 28, 2025
Vaccines Today—November 28, 2025
November 28, 2025
Respiratory Today—November 28, 2025
November 28, 2025